ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.7 | 0.8 | 0.9 |
| Total income | 0.7 | 0.8 | 0.9 |
| Profit before exceptional items & tax | -1.5 | -1.3 | -1.3 |
| Profit before tax | -1.5 | -1.3 | -1.3 |
| Net profit | -1.4 | -1.3 | -1.2 |
| Operating margin | -214.3% | -162.5% | -144.4% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -22.20% |
|---|
BSE results filing, BSE: 540181. Figures extracted from the filing.
Salem Erode Investments Ltd: key numbers
- Share price
- ₹18.55
- Market cap
- ₹42.54 Cr
- Revenue (annual)
- ₹3.51 Cr
- Net profit (annual)
- ₹-4.85 Cr
- P/E (TTM)
- -8.2×Sector 20.8×
- Promoter holding
- 51.45%-23.55% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Salem Erode Investments Ltd
All →Salem Erode Investments Board Meeting Date
Salem Erode Investments will hold a board meeting on November 12, 2026 to approve unaudited standalone results for the quarter and half-year. The notice is a prior intimation under Regulation 29.
Salem Erode Investments Other Announcement
Salem Erode Investments Ltd has filed its quarterly shareholding pattern under Regulation 31. This is a routine regulatory disclosure of share ownership structure.
Salem Erode Investments Capital Structure Change
ICL Fincorp and its PACs acquired 75,99,140 shares of Salem Erode Investments via a rights issue. The group's holding in diluted capital rose to 70.64%.
Salem Erode Investments Management Change
Salem Erode Investments Limited re-appointed Mr. Ambadath Aiyyappan Balan as a Non-Executive Independent Director for a term of 60 months.
Salem Erode Investments Annual General Meeting
Salem Erode Investments Ltd held its 95th Annual General Meeting on September 30, 2026. The meeting covered routine agenda items including financial statement adoption and director re-appointments.
Salem Erode Investments Board Meeting Outcome
Salem Erode Investments extended its rights issue closing date by six days to October 1. Revised allotment and listing dates shift to October 5 and 7 respectively.